Sign in
NTHI Stock Price, Chart, Stats & News
Neonc Technologies Holdings, Inc.
Save
Neonc Technologies Holdings, Inc. (NTHI) does not currently pay a dividend.
67.38M
Market cap
–
Current P/E
–
Forward P/E
NTHI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 54.22% |
Operating margin | -125580.13% |
Pretax margin | -130777.89% |
Net margin | -130777.89% |
Effective tax rate | – |
ROA | -1280.90% |
ROE | 471.81% |
D/E | -0.03x |
Interest coverage ratio | -24.79x |
NTHI valuation
P/E | – |
P/S | 3526.89x |
P/B | -11.82x |
P/CF | -8.33x |
P/FCF | -8.41x |
P/OCF | -8.33x |
PEG | 0.14x |
EV multiple | -2.79x |
About
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Similar securities
Based on sector and market capitalization
Report issue